Laurion Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Laurion Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,453,206	Closed	-$168M	–	628
2023 Q3	$168M	Sell	1,453,206 -115,569	-7%	-$12.4M	1.03%	26
2023 Q2	$161M	Buy	1,568,775 +902,739	+136%	+$95.2M	0.9%	20
2023 Q1	$72.7M	Buy	+666,036	New	+$73.6M	0.49%	49
2021 Q3	–	Sell	-2,773	Closed	-$260K	–	936
2021 Q2	$260K	Buy	+2,773	New	+$255K	﹤0.01%	615
2021 Q1	–	Sell	-19,349	Closed	-$1.42M	–	951
2020 Q4	$1.42M	Buy	+19,349	New	+$1.44M	0.01%	373
2019 Q2	–	Sell	-67,139	Closed	-$1.77M	–	1315
2019 Q1	$1.77M	Buy	+67,139	New	+$1.59M	0.02%	384
2018 Q1	–	Sell	-10,600	Closed	-$155K	–	1871
2017 Q4	$155K	Buy	+10,600	New	+$149K	﹤0.01%	1451
2017 Q3	–	Sell	-128,099	Closed	-$1.52M	–	2021
2017 Q2	$1.52M	Buy	+128,099	New	+$1.59M	0.01%	897
2017 Q1	–	Sell	-27,394	Closed	-$444K	–	1688
2016 Q4	$443K	Buy	+27,394	New	+$497K	﹤0.01%	865
2015 Q3	–	Sell	-174,964	Closed	-$6.08M	–	997
2015 Q2	$6.08M	Buy	174,964 +163,969	+1,491%	+$5M	0.06%	270
2015 Q1	$286K	Buy	+10,995	New	+$202K	0.01%	290
2014 Q4	–	Sell	-57,600	Closed	-$707K	–	472
2014 Q3	$707K	Buy	+57,600	New	+$669K	0.02%	179

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Laurion Capital Management's HZNP Position: Q4 2023 in Review

Laurion Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,453,206 shares — an estimated $168M sold.

Laurion Capital Management first reported a position in HZNP in Q3 2014 and held it in 12 quarters. The position peaked at $168M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Laurion Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Laurion Capital Management sold 1,453,206 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $168M.
Laurion Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 12 quarters.
Laurion Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $168M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.